1,353
Views
0
CrossRef citations to date
0
Altmetric
Clinical Research

Incidence of serum sickness following Indian polyvalent antivenom therapy in a cohort of snake-envenomed patients in rural Sri Lanka

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 518-523 | Received 24 Mar 2023, Accepted 19 Jun 2023, Published online: 24 Jul 2023

References

  • Harrison RA, Hargreaves A, Wagstaff SC, et al. Snake envenoming: a disease of poverty. PLoS Negl Trop Dis. 2009;3(12):e569. doi: 10.1371/journal.pntd.0000569.
  • Gutierrez JM, Williams D, Fan HW, et al. Snakebite envenoming from a global perspective: towards an integrated approach. Toxicon. 2010;56(7):1223–1235. doi: 10.1016/j.toxicon.2009.11.020.
  • Kasturiratne A, Wickremasinghe AR, Silva N D, et al. The global burden of snakebite : a literature analysis and modelling based on regional estimates of envenoming and deaths. PLoS Med. 2008;5(11):e218. doi: 10.1371/journal.pmed.0050218.
  • Gutiérrez JM, Calvete JJ, Habib AG, et al. Snakebite envenoming. Nat Rev Dis Prim. 2017;3:17063.
  • Waiddyanatha S, Silva A, Siribaddana S, et al. Long-term effects of snake envenoming. Toxins. 2019;11(4):193. doi: 10.3390/toxins11040193.
  • Waiddyanatha S, Silva A, Weerakoon K, et al. Long-term health effects perceived by snakebite patients in rural Sri Lanka: a cohort study. PLoS Negl Trop Dis. 2022;16(9):e0010723. doi: 10.1371/journal.pntd.0010723.
  • Silva A, Isbister GK. Current research into snake antivenoms, their mechanisms of action and applications. Biochem Soc Trans. 2020;48(2):537–546. doi: 10.1042/BST20190739.
  • de Silva HA, Ryan NM, de Silva HJ. Adverse reactions to snake antivenom, and their prevention and treatment. Br J Clin Pharmacol. 2016;81(3):446–452. doi: 10.1111/bcp.12739.
  • Isbister, GK, Silva A. Addressing the global challenge of snake envenoming. Lancet. 2018;392:619–620. doi: 10.1111/bcp.12739.
  • Gawarammana I, Kularatne S, Dissanayake W, et al. Parallel infusion of hydrocortisone +/- chlorpheniramine bolus injection to prevent acute adverse reactions to antivenom for snakebites. Med J Aust. 2004;180(1):20–23. doi: 10.5694/j.1326-5377.2004.tb05768.x.
  • Gawarammana I, Keyler DE. Dealing with adverse reactions to snake antivenom. Ceylon Med J. 2011;56(3):87–90. doi: 10.4038/cmj.v56i3.3594.
  • de Silva HA, Pathmeswaran A, Ranasinha CD, et al. Low-dose adrenaline, promethazine, and hydrocortisone in the prevention of acute adverse reactions to antivenom following snakebite: a randomised, double-blind, placebo-controlled trial. PLoS Med. 2011;8(5):e1000435. doi: 10.1371/journal.pmed.1000435.
  • Kularatne SA, Weerakoon K, Silva A, et al. Efficacy of intravenous hydrocortisone administered 2-4 h prior to antivenom as prophylaxis against adverse drug reactions to snake antivenom in Sri Lanka: an open labelled randomized controlled trial. Toxicon. 2016;120:159–165. doi: 10.1016/j.toxicon.2016.08.011.
  • Ryan NM, Kearney RT, Brown SGA, et al. Incidence of serum sickness after the administration of Australian snake antivenom (ASP-22). Clin Toxicol. 2016;54(1):27–33. doi: 10.3109/15563650.2015.1101771.
  • Lovecchio F, Klemens J, Roundy EB, et al. Serum sickness following administration of Antivenin (Crotalidae) Polyvalent in 181 cases of presumed rattlesnake envenomation. Wilderness Environ. Med. 2003;14(4):220–221. doi: 10.1580/1080-6032(2003)14[220:SSFAOA.2.0.CO;2]
  • Shafie NA, Fauzi H, Wahab MSA, et al. The prevalence of hypersensitivity reactions to snake antivenoms administered in Sultanah Nur Zahirah Hospital from 2013 to 2016. Med. J. Malaysia. 2020;75:216–220.
  • Hanauer SB, Wagner CL, Bala M, et al. Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn’s disease. Clin Gastroenterol Hepatol. 2004;2(7):542–553. doi: 10.1016/s1542-3565(04)00238-1.
  • Alhawal S, Aldarwish M, Almoosa Z. Serum sickness following tetanus toxoid injection. Case Rep. Pediatr. 2021;2021:1–3. doi: 10.1155/2021/6680979.
  • Archer BG, Dierks RE. Effects of homologous or heterologous antiserum on neutralizing-antibody response to rabies vaccine. Bull World Health Organ. 1968;39(3):407–417.
  • Leon G, Herrera M, Segura A, et al. Pathogenic mechanisms underlying adverse reactions induced by intravenous administration of snake antivenoms. Toxicon. 2013;76:63–76. doi: 10.1016/j.toxicon.2013.09.010.
  • Lawley T, Bielory L, Gascon P, et al. A prospective clinical and immunologic analysis of patients with serum sickness. N Engl J Med. 1984;311(22):1407–1413. doi: 10.1056/NEJM198411293112204.
  • Lawley TJ, Bielory L, Gascon P, et al. A study of human serum sickness. J. Invest. Dermatol. 1985;85(1):S129–S132. doi: 10.1111/1523-1747.ep12275641.
  • Schaeffer TH, Khatri V, Reifler LM, et al. Incidence of immediate hypersensitivity reaction and serum sickness following administration of Crotalidae polyvalent immune Fab antivenom: a meta-analysis. Acad Emerg Med. 2012;19(2):121–131. doi: 10.1111/j.1553-2712.2011.01276.x.
  • Silva A, Scorgie FE, Lincz LF, et al. Indian polyvalent antivenom accelerates recovery from Venom-Induced consumption coagulopathy (VICC) in Sri Lankan Russell’s viper (Daboia russelii) envenoming. Front Med. 2022;9:1–8. doi: 10.3389/fmed.2022.852651.
  • Waiddyanatha S, Silva A, Weerakoon K, et al. Does snake envenoming cause chronic kidney disease ? A cohort study in rural Sri Lanka. Clin Toxicol. 2023;61(1):47–55. doi: 10.1080/15563650.2022.2147843.
  • Brown SGA. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol. 2004;114(2):371–376. doi: 10.1016/j.jaci.2004.04.029.
  • Pathmeswaran A, Kasturiratne A, Fonseka M, et al. Identifying the biting species in snakebite by clinical features: an epidemiological tool for community surveys. Trans R Soc Trop Med Hyg. 2006;100(9):874–878. doi: 10.1016/j.trstmh.2005.10.003.
  • Silva A, Kuruppu S, Othman I, et al. Neurotoxicity in Sri Lankan Russell’s viper (Daboia russelii) envenoming is primarily due to U1-viperitoxin-Dr1a, a pre-synaptic neurotoxin. Neurotox Res. 2017;31(1):11–19. doi: 10.1007/s12640-016-9650-4.
  • Ruha AM, Curry SC, Beuhler M, et al. Initial postmarketing experience with Crotalidae polyvalent immune fab for treatment of rattlesnake envenomation. Ann Emerg Med. 2002;39(6):609–615. doi: 10.1067/mem.2002.123698.
  • Lavonas EJ, Kokko J, Schaeffer TH, et al. Short-term outcomes after fab antivenom therapy for severe crotaline snakebite. Ann Emerg Med. 2011;57(2):128.e3–137.e3. doi: 10.1016/j.annemergmed.2010.06.550.
  • Bush SP, Green SM, Moynihan JA, et al. Crotalidae polyvalent immune fab (ovine) antivenom is efficacious for envenomations by Southern pacific rattlesnakes (Crotalus helleri). Ann Emerg Med. 2002;40(6):619–624. doi: 10.1067/mem.2002.129939.
  • Misirlioglu ED, Duman H, Ozmen S, et al. Serum sickness-like reaction in children due to cefditoren. Pediatr Dermatol. 2012;29(3):327–328. doi: 10.1111/j.1525-1470.2011.01539.x.
  • Platt R, Dreis MW, Kennedy DL, et al. Serum sickness-like reactions to amoxicillin, cefaclor, cephalexin, and trimethoprim-sulfamethoxazole. J Infect Dis. 1988;158(2):474–477. doi: 10.1093/infdis/158.2.474.
  • Shiari R, Eshgh FA, Rowshanzamir E, et al. Clinical and laboratory profile of serum sickness-like reaction in children. Indian J. Rheumatol. 2011;6(4):173–177. doi: 10.1016/S0973-3698(11)60203-3.
  • Chiong FJK Dr, Loewenthal M, Boyle M, et al. Serum sickness-like reaction after influenza vaccination. BMJ Case Rep. 2015;2015:1–4.
  • Hebert LA, Cosio FG, Neff JC. Diagnostic significance of hypocomplementemia. Kidney Int. 1991;39(5):811–821. doi: 10.1038/ki.1991.102.